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Analysis of a series of 1 cII::a,-antitrypsin (a,AT) gene fusions of different sizes showed that increased a,AT 
expression correlated with the stabilisation of a particular computer-predicted RNA secondary structure. 
Moreover, significant synthesis of unfused a,AT was achieved by reconstruction of this conformation to 
permit interaction between the upstream region of the ribosome-binding site and the first part of the a,AT 
coding sequence. This high-level expression was dependent upon certain silent point mutations in the coding 
sequence, indicating that RNA primary and secondary structure determinants can operate in concert to dic- 
tate the efficiency of protein synthesis. 
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1. INTRODUCTION 
The distance and sequence composition between 
the Shine-Dalgarno element and the start codon 
are important in determining the efficiency of 
mRNA translation in E. coli [1,2]. Moreover, both 
sequence lements should be free from occluding 
secondary structure that may block ribosome ac- 
cess [3-51. It has recently been shown that altera- 
tions to the beginning of the coding sequence can 
also ‘influence gene expression independently of 
secondary structure effects [6]. Here, the role of a 
particular secondary structure in determining the 
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efficiency of protein synthesis was investigated. 
Furthermore, given that ribosomes may recognise 
structural signals as well as the linear nucleotide se- 
quence, it was attempted to engineer effective ex- 
pression of a foreign gene by reconstructing the 
conformation of an endogenous RBS. The model 
used was the bacteriophage h cI1 RBS which has 
been shown to direct efficient expression of CII 
protein in a multicopy plasmid system [7]. We have 
used the gene for human alAT, a protease in- 
hibitor which has potential clinical application in 
the therapy of lung disorders characterized by pro- 
teolytic tissue damage, for example emphysema 
[8]. The expression in E. coli of functionally active 
cviAT and active centre variants of enhanced 
therapeutic potential have been reported [9, lo]. 
2. MATERIALS AND METHODS 
Restriction enzymes were purchased from 
Bethesda Research Laboratories, New England 
Biolabs, Boehringer Mannheim, and Amersham. 
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DNA polymerase, polynucleotide kinase, T4 DNA 
ligase and calf intestinal phosphatase were pur- 
chased from Boehringer Mannheim; Sr nuclease 
was from P-L/Pharmacia. The use of these en- 
zymes and protocols for bacterial transformations, 
DNA preparation and general cloning techniques 
have been described [111. Point mutations were ob- 
tained using in vitro site-directed mutagenesis 
essentially by methods already described [12]. 
Overnight cultures of E. coli strain TGE900 [F- 
su ilv his bio (MBam cIts857 AHI)] containing 
plasmid were grown at 28°C in LB + 100 pg 
Ap/ml. These were diluted into M9 medium con- 
taining 0.2% glucose and amino acid supplements 
and grown at 28°C to an &,00 of 0.3 (1.5 X 10' 
cells per ml). At this point the cultures were divid- 
ed and parallel samples were grown at 28°C (non- 
induced) and at 37°C (induced) for 4 h. De novo 
CQAT synthesis was analyzed by pulse labelling 200 
~1 of culture for 1 min with [35S]methionine (Amer- 
sham; spec. act. > 1000 Ci/mmol) to a final con- 
centration of 10 @X/ml. Labelling was stopped by 
adding 1 ml cold PBS to the samples which were 
then centrifuged for 10 min at 10~ x g, 
resuspended in sample buffer and heated at 1OO’C 
for 5 min. Aliquots containing 50000 cpm 
trichloroacetic acid insoluble radioactivity were 
loaded on SDS-10% PA gels and analyzed by 
fluorography and autoradiography. “C-labelled 
Mr markers were purchased from Bethesda 
Research Laboratories. 10% PA gel analysis of 
unlabelled cell extracts was performed to estimate 
steady-state crlAT levels. Protein was visualised by 
Coomassie blue staining and quantitation was 
achieved by densitometric tracing using a Shimad- 
zu LS-930 scanner. 
Cleared cell lysates were prepared as follows: 
cultures induced as above were harvested by low- 
speed centrifugation and cells were resuspended in 
half the volume of the original culture in TE buf- 
fer. After sonication the samples were centrifuged 
at 10000 x g for 10 min. Total protein in the 
cleared lysates was estimated using the Bio-Rad 
Coomassie blue assay. 
The concentration of curAT in cleared lysates 
was measured by radial immune diffusion 
(Calbiochem~ and elastase inhibitory capacity. 
Elastase assays were performed using 50 ng human 
neutrophil elastase (Elastin Products) prein- 
cubated for 30 min at 23°C with increasing 
184 
amounts of cell extracts before addition of 2 mM 
substrate (~-succinyl-Ala-Ala-Pro-V~-~-nitro- 
anilide; Calbiochem). (wrAT activity was measured 
by monitoring residual elastase activity at 410 nm. 
Possible RNA secondary structures were ob- 
tained using a computer algorithm that determined 
the conformation of minimum free energy [13]. 
For this analysis a relatively narrow sequence win- 
dow was used (I 200 nucleotides) since for the cl1 
RBS efficient translation is achieved with a 150 
nucleotide long fragment spanning the initiation 
codon. This implied that all the elements necessary 
for translation, including possible secondary struc- 
tures, were contained within this fragment. 
3. RESULTS AND DISCUSSION 
Our analysis is based on the structure shown in 
fig.lA, which is similar to that already proposed 
for cI1 mRNA [ 141. All the sequence lements con- 
sidered necessary for initiation of translation are 
contained within this stem-loop conformation. 
The Shine-Dalgarno sequence (AGGAA) and the 
initiation codon are largely accommodated within 
loops, an arrangement thought to be important for 
optimal translation [41. The sequence 
-AAUCAAUUGU- which lies in a loop upstream 
from the Shina-Dalgarno sequence is homologous 
to the IHF box [15]. The major role of IHF is in 
phage X site-specific recombination but recent 
reports have suggested an additional function in 
stimulating ~11 translation [ 16,171. It is conceivable 
that IHF could interact with this sequence lement 
to stimulate translation directly. A striking feature 
of the cII RBS structure is the long double- 
stranded stem that brings together segment -52 to 
-39 upstream from the Shine-Dalgarno sequence 
and 9 to 22, which encodes amino acids 3-7 of the 
CII protein. We have designed a series of plasmid 
constructions to investigate the possible impor- 
tance of this stem structure in the initiation of 
translation. 
A series of gene fusions was constructed with 13, 
8, 5 and 3 N-terminal cI1 codons joined to the 
mature cvrAT coding sequence. Fig.2 shows the ex- 
pression plasmid and the sequence of the 
cII::curAT gene fusions. The original fusion 
(pTG922) contains, from the 5 ‘-end, 13 codons 
from cII,4 codons from a polylinker sequence and 
a mature LYI AT coding sequence lacking only the 5 ’ 
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A 
(Barn HI) 
7aa 5aa 3aa 
pTG922 (AG=-17kcal) 
B 
pTG1905RBSmod (AG.-19kcal) 
Fig.1. Predicted mRNA secondary structures for the 
native A cII ribosome-binding site (RBS) region (A) and 
a modified RBS/aiAT expression construction 
(pTG1905RBSmod) designed to recreate the original 
structure (B). (A) Structure predicted for A cII mRNA 
using the algorithm developed by Zuker and Stiegler [ 131 
with an analysis window of 180 nucleotides. Shown 
(large arrows) are the positions of disruptions of the 
structure by reducing the h ~11: curAT fusions to 7, 5 
and 3 amino acids. (B) Predicted structure for 
pTG1905RBSmod. The plasmid was constructed by 
replacing the segment between the BarnHI and EcoRI 
(indicated by arrows) with a sequence complementary to 
the beginning of the modified cvrAT gene (see text). The 
CY~AT sequence starts immediately after the start codon 
(framed). 
Glu codon. The 7, 5 and 3 amino acid fusions were 
derived from pTG922 by replacing the NdeI- 
BamHI fragment with a synthetic DNA duplex of 
the appropriate sequence. Comparison of the ex- 
pression of these fusions in E. coli allows investiga- 
tion of the effect of progressively reducing the long 
stem of the cI1 RBS structure depicted in fig.lA. 
Each clone was analysed by (i) RID of sonicated 
culture supernatants, (ii) SDS-PAGE of total cell 
proteins, and (iii) SDS-PAGE of pulse-labelled 
newly synthesized proteins. The latter most closely 
reflects translation efficiency since (i) and (ii) 
measure steady-state levels and can be influenced 
by the stability of the protein product. PAGE 
analysis of total cell proteins demonstrated that 
polypeptides of the predicted size (43-45 kDa) 
were synthesized after induction (fig.3A). Den- 
sitometric tracing of the gel lanes indicated that 13, 
7, 5 and 3 amino acid fusions were expressed at 12, 
8.5, 5.5% total cell protein and undetectable 
levels, respectively (table 1). Measurement of (uIAT 
activity in cleared sonicated culture supernatants 
did not reflect this progressive decrease in expres- 
sion; in each case the same level of activity (3 x 
lo5 units/cell) was measured. This is observed 
because the bulk of the fusion protein was 
deposited in insoluble inclusion bodies which pellet 
on centrifugation of the sonicated samples (table 
1). 
Nde I Barn HI 
IAiG GTT CGT GCA AAC AAA CGC ---- Ak]polyliiker 
]A+G GTT CGT GCA AAC AAA &CJ,GAT ----- 
,GAT 
5aa 
3aa 
IASG GTT CGT GCA A~CI,GAT ccc CAG ----- 
CAG GGA GAT ----- 
pTG 929 GAT CCC CAG GGA GAT ------ 
pTG 1905 ATG ,GAAGA~ cci CAL GG; GAT ------ 
Fig.2. Structure of the E. cofi expression vector pTG922 [9,10] and the nucleotide sequences of the 5’ portions of the 
genes studied. 
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Fig.3. SDS-IO% polyacrylamide gel analysis of E. coli cell extracts containing WAT variants. (A) Total cell lysates. 
Lanes: 1, 2, control E. coli TGE900 cultures containing the parental plasmid pTG908 (expression plasmid with no (u~AT 
sequences) at 28°C (non-induced) and 37’C (induced); 3,4,5,6, induced cultures containing the 3, 5, 7 and 13 amino 
acid A ~11: (rrAT fusions. (B) Extracts from [3SS]methionine pulse-labelled cultures. Lanes: 1,2, control cultures con- 
taining the pTG908 at 28°C (non-induced) and 37°C (induced), respectively; 3,4,5,6, induced cultures containing 
pTG929, pTG929RRSmod, pTG1905, pTGl~5RBSmod. Molecular mass markers are indicated in kDa. 
The decrease in expression levels with reducing 
size of cI1 fusion follows the increase in calculated 
free energy of the cII RBS secondary structure 
(- 17, - 15, - 11 and -3 kcal/mol for the 13, 7, 
5 and 3 amino acid fusions, respectively). Also the 
overall shape of the most stable RNA conforma- 
tion does not change significantly until the fusion 
is reduced to 3 amino acids (not shown). These 
data suggest that the efficiency of transfation could 
be directly related to the stability of the ~11 RBS 
stem and Ioop structure. When the first codon of 
mature cvrAT (GAG) is Iinked directly to the initia- 
tion AUG the ~11 RBS stem and loop structure is 
disrupted and there is no expression (see piasmids 
pTG929 and pTG1905, fig.2 and table 1). 
However, if the region 5 ’ to the IHF loop is 
modified to permit interaction with the beginning 
of the turAT gene, then it should be possible to 
reconstruct he original cl1 RBS conformation. To 
achieve this, unique restriction enzyme sites (for 
EcoRI and BarnHI) were generated by site-directed 
mutagenesis at each end of the long stem, as shown 
in fig. IA. After treatment with these enzymes yn- 
thetic DNA fragments were inserted whose plus 
strands were partly complementary to nucleotides 
9-22 of the arrAT gene. In this experiment wo dif- 
186 
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Table 1 
Analysis of CQAT expression in the various constructions 
Vector 
pTG922 
(13 aa) 
7 aa 
5 aa 
3 aa 
Total arAT per cell % CY,AT % cvrAT Vo (Y,AT 
% of total MoWcell 
of newly of total of total 
synthesized soluble insoluble 
cell protein protein protein protein 
12 2 x lo6 28 1.5 25 
8.5 117 x lo6 24 1.5 21 
5.5 lo6 21 1.5 12 
- - - - _ 
pTG929 
pTG929 
RBS mod 
pTG1905 
pTG1905 
RBS mod 
- - _ - - 
- - - - - 
_ - - - 
-1 -2 x lo5 17 0.5 2 
Expression levels relative to total cell protein, newly synthesized protein and total 
insoluble protein were determined by densitometric scanning of PAGE analyses. 
Expression with respect o total soluble protein was measured by radial immune 
diffusion and neutrophil elastase inhibitory capacity. (-) Undetectable arAT; aa, 
amino acid 
November 1986 
ferent cv,AT genes were studied; one carried the 
original cDNA sequence (pTG929), the other being 
altered to generate silent mutations that brought 
the sequence closer to the statistically ‘preferred’ 
sequence for ribosome binding (pTG1905) [ 18,191. 
The inserted upstream sequences were: 5 ‘-GAU- 
CAUAGCUGUGUGGGCA-3 ’ (pTG 1905RBS- 
mod) and 5 ’ -GAUCAUCCUCCUAGGGACA-3 ’ 
(pTG929RBSmod). The sequences of the oligo- 
deoxynucleotides were chosen to allow similarities 
in the following elements with respect to the 
original cI1 structure: (i) the overall shape of the 
structure, (ii) the free energy for the overall struc- 
ture and, (iii) the position of the interior loops and 
the size of IHF loop. The structure of the modified 
RBS for the pTG1905 sequence is shown in fig.lB. 
SDS-PAGE of pulse-labelled samples (fig.3B) 
showed that pTG929 and pTG1905 expressed no 
detectable cuiAT. In the case of pTG1905 with the 
modified upstream region (pTG1905RBSmod), 
there was significant expression (17% of newly 
synthesized protein) whereas there was no ex- 
pression with the modified pTG929 
(pTG929RBSmod). These results were confirmed 
by RID and anti-elastase assays of sonicated 
cultures extracts (table 1). These data suggest that 
the correct secondary structure together with a 
favourable primary structure are required for ef- 
fective protein synthesis. Either feature alone was 
not sufficient for high-level expression. 
Several studies have demonstrated that for effi- 
cient translation the Shine-Dalgarno sequence 
and/or the start codon should be accessible to 
ribosomes and therefore situated either in a region 
free from secondary structure elements or in the 
loop of a hairpin [3,20]. We have shown here that 
the presence of a particular RNA stem-loop struc- 
ture may also be important, at least in the case of 
the cII RBS. This conformation could act to main- 
tain the RBS in a spatial configuration favourable 
for ribosome binding, elongation or perhaps in- 
teraction with IHF. Therefore, to construct an ex- 
pression vector for the production of unfused 
criAT, sequences upstream from the cI1 Shine- 
Dalgarno element were modified so as to 
reconstruct he original cI1 RBS structure. 
This study also illustrates the importance of the 
sequence 3 ’ to the start codon at the level of 
187 
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primary structure alone. Effective expression of 
unfused cvrAT was achieved only when silent muta- 
tions were introduced in codons 2,3,4 and 5 of the 
crrAT gene. Thus, for the efficient expression of a 
foreign gene in E. cob, it may be necessary to 
mutate the nucleotide sequence around the RBS to 
optimize both the primary and secondary structure 
of the mRNA. 
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